• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST段抬高型心肌梗死患者生物可吸收支架植入术后支架周围低强度区域及支架内新生内膜生长情况:一项光学相干断层扫描系列研究

Peri-strut low intensity areas and in-scaffold neointima growth after bioresorbable scaffold implantation in STEMI. A serial optical coherence tomography study.

作者信息

Ochijewicz Dorota, Tomaniak Mariusz, Kołtowski Lukasz, Rdzanek Adam, Pietrasik Arkadiusz, Proniewska Klaudia, Partyka Lukasz, Dijsktra Jouke, Huczek Zenon, Filipiak Krzysztof, Opolski Grzegorz, Kochman Janusz

机构信息

1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

出版信息

Int J Cardiol. 2020 Aug 1;312:27-32. doi: 10.1016/j.ijcard.2020.04.051. Epub 2020 Apr 18.

DOI:10.1016/j.ijcard.2020.04.051
PMID:32315682
Abstract

BACKGROUND

Peri-strut low intensity areas (PLIA) visualized by optical coherence tomography (OCT) have been related to neointimal proliferation and increased incidence of target lesion revascularization in stable coronary artery disease. The aim of this study was to determine the association between PLIA by OCT and the long-term vascular healing response after bioresorbable scaffold (BRS) implantation in the setting of ST-segment elevation myocardial infarction (STEMI).

METHODS

This is a single-centre, longitudinal, cohort study with a serial: baseline, 1, 2 and 5 years OCT evaluation of neointimal response (lumen area and neoatherosclerosis) after percutaneous coronary intervention (PCI) with BRS Absorb™ 1.0 implantation in patients presenting with STEMI. PLIA was analyzed in every cross section and scored: 0-no PLIA; 1-PLIA < 1 quadrant; 2-PLIA ≥ 1 and <2 quadrants; 3-PLIA ≥ 2 and <3 quadrants; 4-PLIA in ≥3 quadrants.

RESULTS

Of the 23 patients implanted BRS, 18 completed 2-year follow-up, whereas complete OCT data up to 5 years were available in 12 patients. Presence of PLIA was identified in 100% patients at 1 and 2 years, whereas at 5 years neither PLIA nor scaffold struts were visualized by OCT. Neoatherosclerosis was identified in 73,68% patients after 1 year and in all patients at 2 and 5 years. The mean PLIA score > 1 at 2 years was associated with greater percentage of minimum lumen area decrease after 2 years from index procedure.

CONCLUSIONS

The extent of PLIA by OCT at 2 years after primary PCI with BRS was associated with lumen area decrease. Neoatherosclerosis formation was detected in all patients at 2 and 5 years. PLIA assessment could serve as an additive means to predict neointimal healing pattern after next generation BRS implantation.

摘要

背景

光学相干断层扫描(OCT)显示的支架周围低强度区域(PLIA)与稳定型冠状动脉疾病中的新生内膜增生及靶病变血运重建发生率增加有关。本研究的目的是确定在ST段抬高型心肌梗死(STEMI)背景下,OCT检测的PLIA与生物可吸收支架(BRS)植入后长期血管愈合反应之间的关联。

方法

这是一项单中心、纵向队列研究,对STEMI患者植入BRS Absorb™ 1.0进行经皮冠状动脉介入治疗(PCI)后,进行系列的基线、1年、2年和5年的OCT评估新生内膜反应(管腔面积和新生动脉粥样硬化)。在每个横截面分析PLIA并进行评分:0-无PLIA;1-PLIA<1个象限;2-PLIA≥1且<2个象限;3-PLIA≥2且<3个象限;4-PLIA≥3个象限。

结果

在23例植入BRS的患者中,18例完成了2年随访,而12例患者可获得长达5年的完整OCT数据。在1年和2年时,100%的患者检测到PLIA,而在5年时,OCT未显示PLIA和支架小梁。1年后,73.68%的患者检测到新生动脉粥样硬化,2年和5年时所有患者均检测到。2年时平均PLIA评分>1与首次手术后2年最小管腔面积减少的百分比更大有关。

结论

BRS初次PCI术后2年时,OCT检测的PLIA范围与管腔面积减少有关。在2年和5年时,所有患者均检测到新生动脉粥样硬化形成。PLIA评估可作为预测下一代BRS植入后新生内膜愈合模式的补充手段。

相似文献

1
Peri-strut low intensity areas and in-scaffold neointima growth after bioresorbable scaffold implantation in STEMI. A serial optical coherence tomography study.ST段抬高型心肌梗死患者生物可吸收支架植入术后支架周围低强度区域及支架内新生内膜生长情况:一项光学相干断层扫描系列研究
Int J Cardiol. 2020 Aug 1;312:27-32. doi: 10.1016/j.ijcard.2020.04.051. Epub 2020 Apr 18.
2
Relationship between peri-strut low intensity areas and vascular healing response after everolimus-eluting bioresorbable scaffold implantation: An optical coherence tomography study.依维莫司洗脱生物可吸收支架植入术后支柱周围低强度区域与血管愈合反应的关系:一项光学相干断层扫描研究。
J Cardiol. 2017 Apr;69(4):606-612. doi: 10.1016/j.jjcc.2016.06.013. Epub 2016 Aug 9.
3
Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold.连续基线、12 个月、24 个月和 60 个月光学相干断层扫描评估急性 ST 段抬高型心肌梗死患者应用 Absorb Bioresorbable Vascular Scaffold 治疗后的情况。
Am J Cardiol. 2021 Sep 15;155:23-31. doi: 10.1016/j.amjcard.2021.05.038. Epub 2021 Jul 25.
4
Third-Generation Sirolimus-Eluting Bioresorbable Tyrocore Scaffold Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Baseline and 6-Month OCT and Clinical Outcomes-a FANTOM STEMI Pilot Study.第三代西罗莫司洗脱生物可吸收雷帕霉素靶向洗脱冠脉雷帕霉素洗脱钴基合金支架在 ST 段抬高型心肌梗死患者中的应用:基线和 6 个月的 OCT 和临床结局——FANTOM STEMI 初步研究。
Cardiovasc Drugs Ther. 2024 Aug;38(4):719-729. doi: 10.1007/s10557-023-07429-0. Epub 2023 Jan 14.
5
First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold.首次基线、12 个月和 24 个月行光学相干断层扫描(OCT)随访评估在接受第二代 Absorb 生物可吸收血管支架治疗的 ST 段抬高型心肌梗死(STEMI)患者中的应用。
EuroIntervention. 2018 Apr 6;13(18):e2201-e2209. doi: 10.4244/EIJ-D-17-00311.
6
Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.药物洗脱生物可吸收支架与药物洗脱金属支架在直接经皮冠状动脉介入治疗后后扩张的效果:TROFI II 血管造影和光学相干断层成像亚研究。
JACC Cardiovasc Interv. 2017 Sep 25;10(18):1867-1877. doi: 10.1016/j.jcin.2017.07.035.
7
Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.急性心肌梗死急性期植入依维莫司洗脱生物可吸收支架的新生内膜覆盖情况及晚期贴壁情况:来自PRAGUE-19研究的光学相干断层扫描数据
Heart Vessels. 2016 Jun;31(6):841-5. doi: 10.1007/s00380-015-0679-8. Epub 2015 Apr 21.
8
A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者植入生物可吸收血管支架后12个月的血管造影和光学相干断层扫描随访
Catheter Cardiovasc Interv. 2015 Oct;86(4):E180-9. doi: 10.1002/ccd.26006. Epub 2015 May 25.
9
Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot study.二代依维莫司洗脱、生物可吸收 Tyrocore 支架在 ST 段抬高型心肌梗死患者中的植入:基线 OCT 和 30 天临床结局——一项 FANTOM STEMI 先导研究。
Catheter Cardiovasc Interv. 2020 Jul;96(1):E1-E7. doi: 10.1002/ccd.28414. Epub 2019 Jul 25.
10
Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: insights from an optical coherence tomography study in humans.评价西罗莫司和紫杉醇洗脱支架植入术后的支架内低强度区:来自人类光学相干断层扫描研究的见解。
Int J Cardiol. 2012 May 17;157(1):38-42. doi: 10.1016/j.ijcard.2010.11.006. Epub 2010 Dec 18.